Welcome to HCV Advocate’s hepatitis blog. The intent of this blog is to keep our website audience up-to-date on information about hepatitis and to answer some of our web site and training audience questions. People are encouraged to submit questions and post comments.

For more information on how to use this blog
, the HCV drug pipeline, and for more information on HCV clinical trials click here

Be sure to check out our other blogs: The HBV Advocate Blog and Hepatitis & Tattoos.

Alan Franciscus
HCV Advocate

Tuesday, April 3, 2012

Metformin Helps Some Cancer Patients

A popular diabetes drug, metformin, appears to help patients with several types of cancer, including cancer of the prostate, liver and pancreas, researchers are revealing or are about to reveal at the American Association For Cancer Research Meeting, 2012, Chicago, USA. Two separate studies showed that metformin, also known by its brand name Glucophage, prolongs life expectancy for patients with early-stage pancreatic cancer, slows down prostate cancer growth, and appears also to help prevent primary liver cancer.

"There have been several retrospective epidemiological studies linking metformin with reduced risk of liver cancer, but our study is the first to formally test whether metformin can protect against carcinogenesis - not just tumor growth and development, but actual tumor formation in the liver." Geoffrey D. Girnun, Ph.D.

Read more....

No comments:

Post a Comment